Samrat Pharmachem Limited reported earnings results for the fourth quarter ended March 31, 2023. For the fourth quarter, the company reported sales was INR 691.81 million compared to INR 601.05 million a year ago. Revenue was INR 692.09 million compared to INR 602.66 million a year ago.

Net loss was INR 7.45 million compared to net income of INR 69.95 million a year ago. Basic loss per share from continuing operations was INR 2.41 compared to basic earnings per share from continuing operations of INR 22.64 a year ago.